Successful Video-Assisted Thoracoscopic Surgery Following Neoadjuvant Chemoimmunotherapy for Stage IIIB Central Squamous Cell Lung Cancer: A Case Report

When surgical treatment is limited in patients with stage IIIA-IIIB non–small cell lung cancer (NSCLC), multimodality treatment can improve long-term outcomes: neoadjuvant chemotherapy to reduce the tumor size followed by radical surgery. In recent years, the combination of standard induction chemotherapy with immune checkpoint inhibitors has been the subject of active debate in the literature. Some studies demonstrate the efficacy of neoadjuvant chemoimmunotherapy, whereas other authors note additional difficulties of surgery after it. In this case report we demonstrate features of surgery in a male patient with stage IIIB central NSCLC after chemoimmunotherapy and discuss difficulties of surgery associated with a minimally invasive video-assisted thoracoscopic surgery approach in complex anatomical lung resection and methods for preventing intraoperative and postoperative complications.

Authors

Institutions

Publication Details

Journal
Innovative medicine of Kuban
Published
2025-05-22
DOI
https://doi.org/10.35401/2541-9897-2025-10-2-112-118
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Successful Video-Assisted Thoracoscopic Surgery Following Neoadjuvant Chemoimmunotherapy for Stage IIIB Central Squamous Cell Lung Cancer: A Case Report

E. I. Zinchenko, Vadim Pischik, Petrov As, D. L. Fateeva
Innovative medicine of Kuban
Lung Cancer Diagnosis and Treatment
article

Successful Video-Assisted Thoracoscopic Surgery Following Neoadjuvant Chemoimmunotherapy for Stage IIIB Central Squamous Cell Lung Cancer: A Case Report

E. I. Zinchenko, Vadim Pischik, Petrov As, D. L. Fateeva
article en

Abstract

When surgical treatment is limited in patients with stage IIIA-IIIB non–small cell lung cancer (NSCLC), multimodality treatment can improve long-term outcomes: neoadjuvant chemotherapy to reduce the tumor size followed by radical surgery. In recent years, the combination of standard induction chemotherapy with immune checkpoint inhibitors has been the subject of active debate in the literature. Some studies demonstrate the efficacy of neoadjuvant chemoimmunotherapy, whereas other authors note additional difficulties of surgery after it. In this case report we demonstrate features of surgery in a male patient with stage IIIB central NSCLC after chemoimmunotherapy and discuss difficulties of surgery associated with a minimally invasive video-assisted thoracoscopic surgery approach in complex anatomical lung resection and methods for preventing intraoperative and postoperative complications.

Innovative medicine of KubanVol. 10(2)
St Petersburg University (RU)
Openalex Percentile: Top 81%
Lung Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.